Expert Interviews

In this discussion, a panel of diabetes management experts examines the groundbreaking potential of teplizumab, the first FDA-approved therapy of its kind, in delaying the onset of T1D stage progression. They discuss its unique mechanism of action and explore its pivotal role in early intervention strategies.

Dr Jennifer D. Goldman and Marianne Briggs, DNP, FNP-C explore the critical role of antibodies in determining T1D progression and emphasize the importance of regular screening. In this segment learn about the four main antibodies pivotal in T1D screening and stage progression.

Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, discusses the stages of T1D progression. She emphasizes the risks of delaying intervention in stage 2 T1D, including heightened DKA risk and severe complications, along with potential treatment efficacy reduction and poorer long-term glycemic control.

Kent Stoneking Pharm D, CDECS, shares his personal T1D story and underscores the critical importance of early diagnosis and intervention for this condition. Following his story, Marianne Briggs, DNP, FNP-C, provides invaluable suggestions for identifying individuals at risk for T1D through effective screening methods.

Kashif Latif, MD defines diabetes, shedding light on the pivotal role of B cells. He introduces the concept of diabetes stages and emphasizes the critical importance of early intervention to prevent complications.

A panel of experts in the management of diabetes addresses the profound burden of type 1 diabetes (T1D), emphasizing heightened familial predisposition for this condition. They explore geographic disparities as well as the role of prediabetes in this patient population.

Shagun Bindlish, MD, discusses the complex interplay between obesity and mental health conditions and how sex is a potential moderating factor.

Medha Munshi, MD, and James Bailey, III, MD, FACE, ECNU, discuss older adult patient cases and review their respective treatment approaches, sharing final takeaways to provide practical insights for managing diabetes in this patient population.

Medical experts discuss the importance of optimizing medication regimens for older patients with diabetes, emphasizing the need to keep treatment plans simple and highlight the value of continuous glucose monitors in monitoring patients and adjusting therapies accordingly.

Key opinion leaders in the management of diabetes discuss the process of deprescribing, or the process of medication simplification to encourage adherence and ease of regimens in older adult populations with type 2 diabetes.